Aliyu Bello Wins $2000 Healthcare Innovation &Tech Advancement Prize

2
893
pharmacy

Pharm. Aliyu Bello Aliyu, a 2017 Pharmacy graduate from the Ahmadu Bello University Zaria, has won a cash prize of $2000 for Healthcare Innovation &Tech Advancement at the just concluded Nigeria-Canada Investment Submit, held in Abuja.

Aliyu, who emerged third among the winners, presented an innovative project on the advancement of technology in healthcare, and his work was featured among the best at the summit.

Aliyu Bello Wins $2000 Healthcare Innovation &Tech Advancement Prize
Pharm. Aliyu Bello Aliyu, receiving a dummy cheque at the summit.

Following this feat, members of the Young Pharmacists Group (YPG) have been felicitating with him on Twitter on this noble achievement, while wishing him greater heights in the nearest future.

Aliyu is the CEO of Myclinic.ng, an online, on-demand platform that enables anyone from anywhere to see and talk to a doctor at anytime simply using a mobile app and all within 5 minutes. The goal of the platform is to minimize costly, time consuming and sometimes unnecessary hospital visits.

READ
Men Can Now Check Their Testicles for Cancer – Research Finds

The platform also integrates diagnostics laboratories across Nigeria which significantly broadens the spectrum of conditions that can be managed using online consultation.

Aliyu Bello Wins $2000 Healthcare Innovation &Tech Advancement Prize
Screenshot of felicitating tweets

The Nigeria-Canada Summit is the flagship event of NCIS LTD/GTE, which brought together world business leaders, top diplomats, senior government officials, development partners, and international trade and investment practitioners from around the world.

Stakeholders in attendance were from both Nigeria and Canada six sectors (Agriculture, Education, Energy, Healthcare, Infrastructure and Mining). The summit also explored and targeted investment opportunities, and strategic business solutions to further the business ventures between Nigeria and Canada.

2 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here